Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 30:376:e067476.
doi: 10.1136/bmj-2021-067476.

How to design high quality acupuncture trials-a consensus informed by evidence

Yu-Qing Zhang  1   2   3   4 , Rui-Min Jiao  1   5 , Claudia M Witt  6 , Lixing Lao  7 , Jian-Ping Liu  8   9 , Lehana Thabane  10 , Karen J Sherman  11   12 , Mike Cummings  13 , Dawn P Richards  14 , Eun-Kyung Anna Kim  15 , Tae-Hun Kim  16   17   18 , Myeong Soo Lee  19   20 , Michael E Wechsler  21 , Benno Brinkhaus  22 , Jun J Mao  23 , Caroline A Smith  24 , Wei-Juan Gang  1   5 , Bao-Yan Liu  25 , Zhi-Shun Liu  26 , Yan Liu  27 , Hui Zheng  28 , Jia-Ni Wu  26 , Alonso Carrasco-Labra  29 , Mohit Bhandari  10 , Philip J Devereaux  10 , Xiang-Hong Jing  1   5 , Gordon Guyatt  3   10
Affiliations

How to design high quality acupuncture trials-a consensus informed by evidence

Yu-Qing Zhang et al. BMJ. .

Erratum in

Abstract

An international panel including patients, clinicians, researchers, acupuncture and surgery trialists, statisticians, and experts in clinical epidemiology and methodology have developed new guidance for randomised controlled trials in acupuncture. It addresses the most prevalent and critical concerns of current acupuncture trials and will help funding agencies, trial registers, and journal editors to evaluate the relevance, importance, and quality of submitted trial proposals and completed trials

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the Unified Competing Interest form (available on request from the corresponding author) and declare: CW received a grant at the University of Zurich from the Kelm Foundation for a randomized controlled trial on acupuncture for dysgeusia during chemotherapy. CW is an unpaid board Member of the Society of Acupuncture Research. KJS received a grant from NIH (National Center for Complementary and Integrative Health). KJS seats on a Data Safety Monitoring Board or Advisory Board from NIH-DoD (Department of Defence)-VA(Veterans Affairs) Collaboratory DSMB, and Advisory Board of the National Center for Complementary and Integrative Health of the US NIH with honorarium. MC receives royalties from non commercially used Medical Acupuncture textbooks.MC works as the Medical Director of the British Medical Acupuncture Society (BMAS) full time. DPR is a volunteer vice president of the Canadian Arthritis Patient Alliance, a patient-led and run arthritis organization that accepts arms-length funding from pharma companies, and an employee of Five02 Labs Inc, under Clinical Trials Ontario to support its patient and public engagement efforts. DPR received an honorarium attend meetings and travel support from Eli Lilly Canada for her speech about living with arthritis and arthritis patient organizations in Canada. MW received grants from the NIH, Sanofi, Astrazeneca Teva, and Jin Hua Foundation Cohero. MW received consulting fees from AstraZeneca, Amgen, Glaxosmithkline, Sanofi, Genzyme, Regeneron, Boehringer Ingelheim, Novartis, genentech, Pulmatrix, Teva, Equillium, cytoreason , Restorbio, Cohero Health, cerecor, incyte, sound biologics, and kinaset. MW received grants for payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AstraZeneca, Glaxosmithkline, Sanofi, and Regeneron. PJD received grants from Abbott Diagnostics, Roche Diagnostics, and Siemens, the monitoring device of CloudDX, and the medical device of Philips Healthcare. PJD reports as a Member of the Scientific Advisory Board of Bayer and Quidel. The study was supported by the China Academy of Chinese Medical Sciences Innovation Fund (CI 2021A03503 & CI2021B011) and “The Belt And Road” Traditional Chinese Medicine Cooperation Project of China Academy of Chinese Medical Sciences; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work of all authors.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. State Council Information Office of the People’s Republic of China. Traditional Chinese medicine in China. 2016. http://www.china.org.cn/chinese/2017-01/17/content_40120942.htm
    1. Su CX. Evaluation of bias in acupuncture randomized controlled trials. [In Chinsese]. Beijing University of Traditional Chinese Medicine, 2015.
    1. Wang YY. Bibliometric study on randomized controlled trials of acupuncture in chinese journals and the influencing factors of positive results. [In Chinese.] Beijing University of Traditional Chinese Medicine, 2014.
    1. Oxman AD, Lombard C, Treweek S, Gagnier JJ, Maclure M, Zwarenstein M. Why we will remain pragmatists: four problems with the impractical mechanistic framework and a better solution. J Clin Epidemiol 2009;62:485-8. 10.1016/j.jclinepi.2008.08.015 - DOI - PubMed
    1. Karanicolas PJ, Montori VM, Devereaux PJ, Schünemann H, Guyatt GH. A new “mechanistic-practical” framework for designing and interpreting randomized trials. J Clin Epidemiol 2009;62:479-84. 10.1016/j.jclinepi.2008.02.009 - DOI - PubMed

Publication types